Skip to main content
. 2021 Aug 30;4(1):28–36. doi: 10.1016/j.cjco.2021.08.012

Table 1.

Characteristics, anthropometrics, and clinical findings of study subjects at study visit

Characteristic MUL patients (n = 23)
Control subjects (n = 23)
P
Mean or median SD or range Mean or median SD or range
Male sex, n 11 11
Age, y 10.3 1.9–15.2 10.0 1.2–15.8 NS
Weight, kg 14.8 6.6–47.0 33.0 13.0–68.7 < 0.001
Weight-for-age, Z –5.17 2.78 0.20 0.96 < 0.001
Weight-for-height, Z –2.11 1.70 0.08 0.94 < 0.001
Weight-for-height, % –13.3 8.83 0.92 12.7 < 0.001
Height, cm 110.5 69.5–157 146.4 93–175.5 < 0.001
Height-for-age, Z –4.47 –10.4–1.10 0.20 –3.34–1.85 < 0.001
Lean body mass 14.7 6.8–36.1 29.5 11.3 – 46.2 < 0.001
Waist-to-hip ratio 0.93 0.73–1.23 0.85 0.71–1.22 0.007
Body surface area, m2 0.66 0.36–1.43 1.15 0.58–1.78 < 0.001
Thorax circumference, mm 508 395–790 655 507–800 < 0.001
Laboratory data
Alanine aminotransferase, U/l 35 19 NA
Pro-BNP, ng/l 385 682
Clinical findings
Estimated jugular venous pressure, mm Hg 7 3 Veins not observable
Liver (cm from right costal margin) 2 0–5 Liver not palpable
Modified Ross score 1 0–13 0
Modified Ross class 1 1–3 1
Systolic BP, mm Hg 95 13 104 10 0.009
Systolic BP, Z –0.14 1.32 0.27 0.67 0.210
Diastolic BP, mm Hg 58 7 60 7 0.405
Diastolic BP, Z –0.16 1.22 0.13 0.52 0.310
Heart rate, bpm 91 20 76 14 0.005

Data are presented as mean and standard deviation (SD), median and range, or count and percentage, unless otherwise specified.

BP, blood pressure. bpm, beats per minute; NA, not assessed; NS nonsignificant. pro-BNP, pro-hormone brain natriuretic peptide.

N = 18 for lean body mass for mulibrey nanism (MUL) patients and individually matched control subjects.